Report Detail
Global Iron Chelation Drug Market Growth 2019-2024
- RnM3040311 |
- 28 February, 2019 |
- Global |
- 133 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
This report studies the Iron Chelation Drug market. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 μg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.
North America is the largest consumption region of Iron Chelation Drug, with a consumption value market share nearly 31.03% in 2016. Europe is the second largest consumption region of Iron Chelation Drug, enjoying consumption value market share nearly 25.30% in 2016. Apotex, Cipla and other company are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Iron Chelation Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Iron Chelation Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Iron Chelation Drug market by product type, application, key manufacturers and key regions and countries.
This study considers the Iron Chelation Drug value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Deferoxamine
Deferiprone
Deferasirox
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Transfusional Iron Overload
NTDT Caused Iron Overload
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Apotex Inc. (Canada)
Cipla (India)
Novartis (Switzerland)
Sun Pharma (India)
Natco Pharma (India)
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Iron Chelation Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Iron Chelation Drug market by identifying its various subsegments.
Focuses on the key global Iron Chelation Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Iron Chelation Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Iron Chelation Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Iron Chelation Drug Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Iron Chelation Drug Consumption 2014-2024
- 2.1.2 Iron Chelation Drug Consumption CAGR by Region
- 2.2 Iron Chelation Drug Segment by Type
- 2.2.1 Deferoxamine
- 2.2.2 Deferiprone
- 2.2.3 Deferasirox
- 2.3 Iron Chelation Drug Consumption by Type
- 2.3.1 Global Iron Chelation Drug Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Iron Chelation Drug Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Iron Chelation Drug Sale Price by Type (2014-2019)
- 2.4 Iron Chelation Drug Segment by Application
- 2.4.1 Transfusional Iron Overload
- 2.4.2 NTDT Caused Iron Overload
- 2.5 Iron Chelation Drug Consumption by Application
- 2.5.1 Global Iron Chelation Drug Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Iron Chelation Drug Value and Market Share by Application (2014-2019)
- 2.5.3 Global Iron Chelation Drug Sale Price by Application (2014-2019)
3 Global Iron Chelation Drug by Players
- 3.1 Global Iron Chelation Drug Sales Market Share by Players
- 3.1.1 Global Iron Chelation Drug Sales by Players (2017-2019)
- 3.1.2 Global Iron Chelation Drug Sales Market Share by Players (2017-2019)
- 3.2 Global Iron Chelation Drug Revenue Market Share by Players
- 3.2.1 Global Iron Chelation Drug Revenue by Players (2017-2019)
- 3.2.2 Global Iron Chelation Drug Revenue Market Share by Players (2017-2019)
- 3.3 Global Iron Chelation Drug Sale Price by Players
- 3.4 Global Iron Chelation Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Iron Chelation Drug Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Iron Chelation Drug Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Iron Chelation Drug by Regions
- 4.1 Iron Chelation Drug by Regions
- 4.1.1 Global Iron Chelation Drug Consumption by Regions
- 4.1.2 Global Iron Chelation Drug Value by Regions
- 4.2 Americas Iron Chelation Drug Consumption Growth
- 4.3 APAC Iron Chelation Drug Consumption Growth
- 4.4 Europe Iron Chelation Drug Consumption Growth
- 4.5 Middle East & Africa Iron Chelation Drug Consumption Growth
5 Americas
- 5.1 Americas Iron Chelation Drug Consumption by Countries
- 5.1.1 Americas Iron Chelation Drug Consumption by Countries (2014-2019)
- 5.1.2 Americas Iron Chelation Drug Value by Countries (2014-2019)
- 5.2 Americas Iron Chelation Drug Consumption by Type
- 5.3 Americas Iron Chelation Drug Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Iron Chelation Drug Consumption by Countries
- 6.1.1 APAC Iron Chelation Drug Consumption by Countries (2014-2019)
- 6.1.2 APAC Iron Chelation Drug Value by Countries (2014-2019)
- 6.2 APAC Iron Chelation Drug Consumption by Type
- 6.3 APAC Iron Chelation Drug Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Iron Chelation Drug by Countries
- 7.1.1 Europe Iron Chelation Drug Consumption by Countries (2014-2019)
- 7.1.2 Europe Iron Chelation Drug Value by Countries (2014-2019)
- 7.2 Europe Iron Chelation Drug Consumption by Type
- 7.3 Europe Iron Chelation Drug Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Iron Chelation Drug by Countries
- 8.1.1 Middle East & Africa Iron Chelation Drug Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Iron Chelation Drug Value by Countries (2014-2019)
- 8.2 Middle East & Africa Iron Chelation Drug Consumption by Type
- 8.3 Middle East & Africa Iron Chelation Drug Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Iron Chelation Drug Distributors
- 10.3 Iron Chelation Drug Customer
11 Global Iron Chelation Drug Market Forecast
- 11.1 Global Iron Chelation Drug Consumption Forecast (2019-2024)
- 11.2 Global Iron Chelation Drug Forecast by Regions
- 11.2.1 Global Iron Chelation Drug Forecast by Regions (2019-2024)
- 11.2.2 Global Iron Chelation Drug Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Iron Chelation Drug Forecast by Type
- 11.8 Global Iron Chelation Drug Forecast by Application
12 Key Players Analysis
- 12.1 Apotex Inc. (Canada)
- 12.1.1 Company Details
- 12.1.2 Iron Chelation Drug Product Offered
- 12.1.3 Apotex Inc. (Canada) Iron Chelation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Apotex Inc. (Canada) News
- 12.2 Cipla (India)
- 12.2.1 Company Details
- 12.2.2 Iron Chelation Drug Product Offered
- 12.2.3 Cipla (India) Iron Chelation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Cipla (India) News
- 12.3 Novartis (Switzerland)
- 12.3.1 Company Details
- 12.3.2 Iron Chelation Drug Product Offered
- 12.3.3 Novartis (Switzerland) Iron Chelation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Novartis (Switzerland) News
- 12.4 Sun Pharma (India)
- 12.4.1 Company Details
- 12.4.2 Iron Chelation Drug Product Offered
- 12.4.3 Sun Pharma (India) Iron Chelation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Sun Pharma (India) News
- 12.5 Natco Pharma (India)
- 12.5.1 Company Details
- 12.5.2 Iron Chelation Drug Product Offered
- 12.5.3 Natco Pharma (India) Iron Chelation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Natco Pharma (India) News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Iron Chelation Drug . Industry analysis & Market Report on Iron Chelation Drug is a syndicated market report, published as Global Iron Chelation Drug Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Iron Chelation Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
